VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial
Vedanta Biosciences, Inc.
Thomas Louie; Yoav Golan; Sahil Khanna; Dmitri Bobilev; Nathalie Erpelding; Candida Fratazzi; Meg Carini; Rajita Menon; Mary Ruisi; Jason M Norman; Jeremiah J Faith; Bernat Olle; Minran Li; Jeffrey L Silber; Darrell S Pardi